Literature DB >> 2232489

A phenomenological interpretation of the variation in dialysate volume with dwell time in CAPD.

G Stelin1, B Rippe.   

Abstract

Intraperitoneal fluid volume (IPV) changes versus time were followed in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) using a simple volume recovery method. In each patient dialysates containing 1.36 and 3.86 percent glucose as an osmotic agent were investigated. The patients' IPV versus time data were fitted to a function determined by four "arbitrary" coefficients, from which both the initial ultrafiltration (UF) rate immediately following intraperitoneal (i.p.) fluid instillation and the "final" peritoneal-to-blood fluid absorption rate could be assessed. The peritoneal osmotic conductance to glucose, that is, the peritoneal ultrafiltration coefficient (Kf), times the peritoneal osmotic reflection coefficient to glucose (sigma g), Kf sigma g, was determined using two related approaches. Kf sigma g is a major determinant of the transperitoneal volume exchange, and it was calculated to be 3.54 +/- 0.85 (+/- SE) and 3.81 +/- 0.52 microliters/min/mm Hg, respectively, depending on the assumption employed. Kf sigma g was further analysed according to a three-pore model of membrane permeability to determine the possible range of Kf and sigma g compatible with a peritoneal small solute sieving coefficient (phi) ranging from 0.3 to 0.61. According to these calculations both Kf and sigma g ranged from 0.043 to 0.081 (ml/min/mm Hg and dimensionless, respectively). The maximal peritoneal lymph flow (L) realistic according to this analysis, and compatible with a measured total peritoneal-to-blood fluid absorption rate of 1.25 +/- 0.14 ml/min, was 0.75 ml/min, the most plausible values, however, falling between 0.3 to 0.5 ml/min.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2232489     DOI: 10.1038/ki.1990.227

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Threefold peritoneal test of osmotic conductance, ultrafiltration efficiency, and fluid absorption.

Authors:  Jacek Waniewski; Ramón Paniagua; Joanna Stachowska-Pietka; María-de-Jesús Ventura; Marcela Ávila-Díaz; Carmen Prado-Uribe; Carmen Mora; Elvia García-López; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2013-02-01       Impact factor: 1.756

Review 2.  Can Free Water Transport Be Used as a Clinical Parameter for Peritoneal Fibrosis in Long-Term PD Patients?

Authors:  Raymond T Krediet; Deirisa Lopes Barreto; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

3.  Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer.

Authors:  Paul H Sugarbaker; Kurt Van der Speeten; O Anthony Stuart
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

4.  Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.

Authors:  Alp Akonur; Clifford J Holmes; John K Leypoldt
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

5.  Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients.

Authors:  K Van der Speeten; K Govaerts; O A Stuart; P H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-06-13       Impact factor: 2.260

6.  Peritoneal dialysis: from bench to bedside.

Authors:  Raymond T Krediet
Journal:  Clin Kidney J       Date:  2013-10-14

7.  AQP1-Containing Exosomes in Peritoneal Dialysis Effluent As Biomarker of Dialysis Efficiency.

Authors:  Simone Corciulo; Maria Celeste Nicoletti; Lisa Mastrofrancesco; Serena Milano; Maria Mastrodonato; Monica Carmosino; Andrea Gerbino; Roberto Corciulo; Roberto Russo; Maria Svelto; Loreto Gesualdo; Giuseppe Procino
Journal:  Cells       Date:  2019-04-09       Impact factor: 6.600

8.  Aquaporin-1 Facilitates Transmesothelial Water Permeability: In Vitro and Ex Vivo Evidence and Possible Implications in Peritoneal Dialysis.

Authors:  Francesca Piccapane; Andrea Gerbino; Monica Carmosino; Serena Milano; Arduino Arduini; Lucantonio Debellis; Maria Svelto; Rosa Caroppo; Giuseppe Procino
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

Review 9.  Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.

Authors:  Kurt Van der Speeten; Oswald Anthony Stuart; Paul H Sugarbaker
Journal:  Curr Drug Discov Technol       Date:  2009-03

10.  Optimizing Automated Peritoneal Dialysis Using an Extended 3-Pore Model.

Authors:  Carl M Öberg; Bengt Rippe
Journal:  Kidney Int Rep       Date:  2017-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.